232 related articles for article (PubMed ID: 30776371)
1. Ameliorating gut microenvironment through staphylococcal nuclease-mediated intestinal NETs degradation for prevention of type 1 diabetes in NOD mice.
Liang Y; Wang X; He D; You Q; Zhang T; Dong W; Fei J; Xing Y; Wu J
Life Sci; 2019 Mar; 221():301-310. PubMed ID: 30776371
[TBL] [Abstract][Full Text] [Related]
2. Oral delivery of staphylococcal nuclease by Lactococcus lactis prevents type 1 diabetes mellitus in NOD mice.
Lang J; Wang X; Liu K; He D; Niu P; Cao R; Jin L; Wu J
Appl Microbiol Biotechnol; 2017 Oct; 101(20):7653-7662. PubMed ID: 28889199
[TBL] [Abstract][Full Text] [Related]
3. Oral delivery of staphylococcal nuclease ameliorates DSS induced ulcerative colitis in mice via degrading intestinal neutrophil extracellular traps.
Dong W; Liu D; Zhang T; You Q; Huang F; Wu J
Ecotoxicol Environ Saf; 2021 Jun; 215():112161. PubMed ID: 33812202
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of PAD4-mediated NET formation by cl-amidine prevents diabetes development in nonobese diabetic mice.
Shen Y; You Q; Wu Y; Wu J
Eur J Pharmacol; 2022 Feb; 916():174623. PubMed ID: 34767782
[TBL] [Abstract][Full Text] [Related]
5. Modulation of Gut Microbiota by Low Methoxyl Pectin Attenuates Type 1 Diabetes in Non-obese Diabetic Mice.
Wu C; Pan LL; Niu W; Fang X; Liang W; Li J; Li H; Pan X; Chen W; Zhang H; Lakey JRT; Agerberth B; de Vos P; Sun J
Front Immunol; 2019; 10():1733. PubMed ID: 31417546
[TBL] [Abstract][Full Text] [Related]
6. Prolonged antibiotic treatment induces a diabetogenic intestinal microbiome that accelerates diabetes in NOD mice.
Brown K; Godovannyi A; Ma C; Zhang Y; Ahmadi-Vand Z; Dai C; Gorzelak MA; Chan Y; Chan JM; Lochner A; Dutz JP; Vallance BA; Gibson DL
ISME J; 2016 Feb; 10(2):321-32. PubMed ID: 26274050
[TBL] [Abstract][Full Text] [Related]
7. Frontline Science: Abnormalities in the gut mucosa of non-obese diabetic mice precede the onset of type 1 diabetes.
Miranda MCG; Oliveira RP; Torres L; Aguiar SLF; Pinheiro-Rosa N; Lemos L; Guimarães MA; Reis D; Silveira T; Ferreira Ê; Moreira TG; Cara DC; Maioli TU; Kelsall BL; Carlos D; Faria AMC
J Leukoc Biol; 2019 Sep; 106(3):513-529. PubMed ID: 31313381
[TBL] [Abstract][Full Text] [Related]
8. Clostridial Butyrate Biosynthesis Enzymes Are Significantly Depleted in the Gut Microbiota of Nonobese Diabetic Mice.
Tanca A; Palomba A; Fraumene C; Manghina V; Silverman M; Uzzau S
mSphere; 2018 Oct; 3(5):. PubMed ID: 30355671
[TBL] [Abstract][Full Text] [Related]
9. Oral Probiotic VSL#3 Prevents Autoimmune Diabetes by Modulating Microbiota and Promoting Indoleamine 2,3-Dioxygenase-Enriched Tolerogenic Intestinal Environment.
Dolpady J; Sorini C; Di Pietro C; Cosorich I; Ferrarese R; Saita D; Clementi M; Canducci F; Falcone M
J Diabetes Res; 2016; 2016():7569431. PubMed ID: 26779542
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil Extracellular Traps Caused by Gut Leakage Trigger the Autoimmune Response in Nonobese Diabetic Mice.
You Q; Shen Y; Wu Y; Li Y; Liu C; Huang F; Gu HF; Wu J
Front Immunol; 2021; 12():711423. PubMed ID: 35111148
[TBL] [Abstract][Full Text] [Related]
11. Recombinant
Preisser TM; da Cunha VP; Santana MP; Pereira VB; Cara DC; Souza BM; Miyoshi A
J Diabetes Res; 2021; 2021():6697319. PubMed ID: 33604389
[TBL] [Abstract][Full Text] [Related]
12. Spatial variations in gut permeability are linked to type 1 diabetes development in non-obese diabetic mice.
Joesten WC; Short AH; Kennedy MA
BMJ Open Diabetes Res Care; 2019; 7(1):e000793. PubMed ID: 31908796
[TBL] [Abstract][Full Text] [Related]
13. Specific inulin-type fructan fibers protect against autoimmune diabetes by modulating gut immunity, barrier function, and microbiota homeostasis.
Chen K; Chen H; Faas MM; de Haan BJ; Li J; Xiao P; Zhang H; Diana J; de Vos P; Sun J
Mol Nutr Food Res; 2017 Aug; 61(8):. PubMed ID: 28218451
[TBL] [Abstract][Full Text] [Related]
14. Increased formation of neutrophil extracellular traps is associated with gut leakage in patients with type 1 but not type 2 diabetes.
You Q; He DM; Shu GF; Cao B; Xia YQ; Xing Y; Ni M; Chen JF; Shi SL; Gu HF; Liu Y; Wu J
J Diabetes; 2019 Aug; 11(8):665-673. PubMed ID: 30592146
[TBL] [Abstract][Full Text] [Related]
15. Innate immunity and intestinal microbiota in the development of Type 1 diabetes.
Wen L; Ley RE; Volchkov PY; Stranges PB; Avanesyan L; Stonebraker AC; Hu C; Wong FS; Szot GL; Bluestone JA; Gordon JI; Chervonsky AV
Nature; 2008 Oct; 455(7216):1109-13. PubMed ID: 18806780
[TBL] [Abstract][Full Text] [Related]
16. Targeting gut microbiota and barrier function with prebiotics to alleviate autoimmune manifestations in NOD mice.
Hansen CHF; Larsen CS; Petersson HO; Zachariassen LF; Vegge A; Lauridsen C; Kot W; Krych Ł; Nielsen DS; Hansen AK
Diabetologia; 2019 Sep; 62(9):1689-1700. PubMed ID: 31139852
[TBL] [Abstract][Full Text] [Related]
17. Administration of Human Derived Upper gut Commensal Prevotella histicola delays the onset of type 1 diabetes in NOD mice.
Marietta E; Horwath I; Meyer S; Khaleghi-Rostamkolaei S; Norman E; Luckey D; Balakrishnan B; Mangalam A; Choung RS; Taneja V; Murray JA
BMC Microbiol; 2022 Jan; 22(1):8. PubMed ID: 34983374
[TBL] [Abstract][Full Text] [Related]
18. The Contribution of Neutrophils and NETs to the Development of Type 1 Diabetes.
Petrelli A; Popp SK; Fukuda R; Parish CR; Bosi E; Simeonovic CJ
Front Immunol; 2022; 13():930553. PubMed ID: 35874740
[TBL] [Abstract][Full Text] [Related]
19. Loss of gut barrier integrity triggers activation of islet-reactive T cells and autoimmune diabetes.
Sorini C; Cosorich I; Lo Conte M; De Giorgi L; Facciotti F; Lucianò R; Rocchi M; Ferrarese R; Sanvito F; Canducci F; Falcone M
Proc Natl Acad Sci U S A; 2019 Jul; 116(30):15140-15149. PubMed ID: 31182588
[TBL] [Abstract][Full Text] [Related]
20.
Hänninen A; Toivonen R; Pöysti S; Belzer C; Plovier H; Ouwerkerk JP; Emani R; Cani PD; De Vos WM
Gut; 2018 Aug; 67(8):1445-1453. PubMed ID: 29269438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
